Incyte (($INCY)) announced an update on their ongoing clinical study. Incyte Corporation is currently conducting a clinical study titled ‘An ...

Bayer AG (($BAYRY)) announced an update on their ongoing clinical study. Study Overview: Bayer AG is conducting a Phase 1 study titled A Phase 1, ...

In the wake of recent reports of cough syrup contamination with Diethylene Glycol (DEG), the Central Drugs Standard Control ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase 1 clinical trial of TLX090 (153Samarium (Sm)-DOTMP), a therapeutic ...

The Central Drugs Standard Control Organisation (CDSCO) has issued a warning after the State Drug Testing Laboratory (SDTL) ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the ...

Raising Up to $5 Million to Support Rapid Expansion of Breakthrough, Clinically Proven Unbuzzd Beverage Hosting Live Webinar ...

Cardiawave, a pioneering medtech company developing non-invasive ultrasound therapy (NIUT) for aortic stenosis, today announced the appointment of Jonathan Freeman, PhD, as Chairman of its Board of ...

Myosin Therapeutics, Inc., a clinical-stage biotechnology company developing first-in-class therapies that modulate molecular motor proteins, today announced that the U.S. Food and Drug Administration ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that it has dosed the first patient in a Phase ...

During the webinar, Unbuzzd CEO John Duffy, Advisor Jason Sawyer, Medical Director Dr. Eric Hoskins, and Board Co-Chair Gerry David, former CEO of Celsius, will discuss the current investment ...